Anti–SARS-CoV-2 antibody responses in patients with IBD treated with biologics: are we finding CLARITY?

Thomas P. Chapman; Joana Revés; Joana Torres; Jack Satsangi

doi:10.1053/j.gastro.2021.09.019

Anti–SARS-CoV-2 antibody responses in patients with IBD treated with biologics: are we finding CLARITY?

Thomas P. Chapman, Joana Revés, Joana Torres, Jack Satsangi

Research output: Contribution to journal › Comment/debate

1 Citation (Scopus)

Original language	English
Pages (from-to)	2057-2059
Number of pages	3
Journal	Gastroenterology
Volume	161
Issue number	6
DOIs	https://doi.org/10.1053/j.gastro.2021.09.019
Publication status	Published - Dec 2021
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1053/j.gastro.2021.09.019

Cite this

@article{50b99e30745e43dd933541f5f37d9b5f,

title = "Anti–SARS-CoV-2 antibody responses in patients with IBD treated with biologics: are we finding CLARITY?",

author = "Chapman, {Thomas P.} and Joana Rev{\'e}s and Joana Torres and Jack Satsangi",

year = "2021",

month = dec,

doi = "10.1053/j.gastro.2021.09.019",

language = "English",

volume = "161",

pages = "2057--2059",

journal = "Gastroenterology",

issn = "0016-5085",

publisher = "W.B. Saunders",

number = "6",

}

TY - JOUR

T1 - Anti–SARS-CoV-2 antibody responses in patients with IBD treated with biologics

T2 - are we finding CLARITY?

AU - Chapman, Thomas P.

AU - Revés, Joana

AU - Torres, Joana

AU - Satsangi, Jack

PY - 2021/12

Y1 - 2021/12

UR - http://www.scopus.com/inward/record.url?scp=85122111408&partnerID=8YFLogxK

U2 - 10.1053/j.gastro.2021.09.019

DO - 10.1053/j.gastro.2021.09.019

M3 - Comment/debate

C2 - 34529994

AN - SCOPUS:85122111408

SN - 0016-5085

VL - 161

SP - 2057

EP - 2059

JO - Gastroenterology

JF - Gastroenterology

IS - 6

ER -

Anti–SARS-CoV-2 antibody responses in patients with IBD treated with biologics: are we finding CLARITY?

UN SDGs

Access to Document

Other files and links

Cite this